| Net Cash Provided by (Used in) Operating Activities |
-17.4K |
USD |
-312% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
19.7K |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500M |
shares |
+400% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
110M |
shares |
+9.5% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
2.35K |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
3.75K |
USD |
+296% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
412K |
USD |
+21.5% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
412K |
USD |
+21.5% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
-95.5K |
USD |
-20.7% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
11.9K |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Interest Expense |
8.28K |
USD |
+10.1% |
Q1 2025 |
Q1 2025 |